undefined undefined
NaN.000
NaN.00%
Tenured Life Sciences Executive Joins AI-Driven Drug Discovery Company to Provide Strategic Guidance and Support Pipeline Growth LA JOLLA, Calif., April 24, 2024 /PRNewswire/ -- Model Medici...
04-24 20:30
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaini...
04-23 02:46
Updates on Hepion Pharmaceuticals' ASCEND-NASH Trial, now in wind-down phase. Explore insights into Phase 2b study progression and strategic alternatives.
04-23 02:14
Gainers: Matterport (MTTR) +180%. mF International Ltd (MFI) +149%. Edible Garden AG (EDBL) +84%. AGBA Group Holding Limited (AGBA) +81%. Moolec Science (MLEC) +64%. NKGen Biotech (NKGN) +28%. Tungray...
04-23 00:52
Gainers NKGen Biotech (NASDAQ:NKGN) shares rose 33.8% to $1.48 during Monday's...
04-23 00:31
U.S. stocks traded higher midway through trading, with the Dow Jones gaining ar...
04-23 00:07
Gainers: Moolec Science SA (MLEC) +86%. NKGen Biotech (NKGN) +18%. Protara Therapeutics (TARA) +13%. Lexicon Pharmaceuticals (LXRX) +11%. ProKidney (PROK) +7%. Losers: Hepion Pharmaceuticals (HEPA) -3...
04-22 22:01
Losers: Hepion Pharmaceuticals (HEPA) -38% initiates wind-down activities in Phase 2b ‘ASCEND-NASH’ trial. Top Wealth Group Holding Limited (TWG) -17%. Redwoods Acquisition Corp (RWOD) -13%. Sunshine ...
04-22 20:23
Hepion Pharmaceuticals Shares Resumed Trading
04-20 05:05
Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic steatohepatitis ("NASH"), hepatocellular carcinoma ("HCC"), and other chronic
04-20 04:33